P-111 PERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification
Conference Paper
Full Text
Duke Authors
Cited Authors
- Tabernero, J; Bekaii-Saab, T; Safont Aguilera, M; Cubillo, A; Garcia-Carbonero, R; Limon, L; Rodríguez-Salas, N; Tournigand, C; Borg, C; Raghav, K; Finley, G; Strickler, J; Beier, F; Salim, S; Esser, R; Liu, E; Adrian, S; López-López, C
Published Date
- July 2021
Published In
Volume / Issue
- 32 /
Start / End Page
- S136 - S137
Published By
International Standard Serial Number (ISSN)
- 0923-7534
Digital Object Identifier (DOI)
- 10.1016/j.annonc.2021.05.166